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ABSTRACT 
 
 
 
A recent application of the peptide strings concept has yielded novel perceptions on 
cell growth regulation, for instance that of oncoprotein metastasis. Here, this 
interdisciplinary approach at the boundary between physics and biology has been 
applied to gain a more profound insight into rheumatoid arthritis. As a result of the 
present investigation, this disease could be viewed as due to a metabolic 
dysregulation/syndrome-associated breakdown in the immunoglobulin A-based 
surveillance of the potentially pathogenic fungus Candida albicans that subsequently 
engenders a widespread self-destruction through cross-reactive auto-epitopes, 
ultimately amounting to the systemic predominance of a pro-inflammatory peptide 
string. Its therapeutic counterpart equally proposed in this report might serve as a 
model for future strategies against autoimmunity. 
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About 2 years ago, Weyand and Goronzy summarized the molecular complexity of 
rheumatoid arthritis (RA) and emphasized that its seemingly disparate aspects are 
still in need of a basic explanation, thereby calling for a sort of (physical) string 
theory to reconcile the various pathophysiologic details of this autoimmune disease 
(1). This appeal prompted me to explore whether my interdisciplinary concepts on 
defensology (2) and peptide strings (3-5) could yield some useful insights towards a 
more simplified and fundamental view on RA. 
Since one of the hallmarks of RA is the so-called rheumatoid factor (RF), i.e. 
an autoantibody directed against the constant region of IgG, i.e. immunoglobulin G 
(6), I first addressed the issue as to whether the tetrapeptide fragment Thr-Lys-Val-
Asp (TKVD) that I had discovered (2) to be shared by the constant region of IgG1 and 
the retinoblastoma tumor suppressor protein (RB) could be part of an 
immunoregulatory peptide string which may have become deregulated in RA. 
Peptide strings are an emergent property of biologically important 
proteins/peptides whereby these molecules display the following features (4,5): 
a)  related to each other in that they share a distinct amino acid motif 
(associated with a common biological function); 
b) besides the above functional agonism as defined in a) and depending on 
a given cellular context, equally capable of functional antagonism 
and/or of binding to one another (as a result of molecular 
complementariness); 
c) capable of self-binding and/or containing functionally antagonistic 
domains/fragments whereby one of the two counterparts carries the 
common motif defined in a); 
d) able to translocate across relatively large subcellular distances (e.g. from 
the cell nucleus/cytosol to the extracellular space and/or vice versa); 
e) if considered together as one functional unit, found, by abstraction, to 
trace a transcellular route across cells. 
Briefly, a peptide string can emerge from functional links between an 
extracellular protein, a cytoplasmic protein and a nuclear protein, any of which is 
able to translocate to one another´s  compartment and to bind each other as well as 
to self-associate through common amino acid motifs, as initially illustrated for 
oncogenic and anti-oncogenic processes (4). 
The minimum requirement for a peptide string, however, is probably even 
less: a self-binding protein with functionally antagonistic domains as well as dual or 
triple (extracellular/cytoplasmic/nuclear) localization in which either of 2 possible 
antagonistic peptide strings can be "imprinted" depending on the nature of the 
environmental/hormonal cue to which it both binds and resembles (qualitative 
aspect) and, moreover, by the amount of such interactions over spacetime 
(quantitative aspect). For instance, a growth-inhibitory RB peptide string 
corresponds to relatively few insulin-RB complex formations across one or more cells 
whereas a growth-promoting RB peptide string emerges when such insulin-bound RB 
fraction outnumbers the amount of free RB (or yet E2F-bound) molecules (5). 
Interestingly, this latter RB string is well-suited to explain the recently observed 
oncogenic implication of RB in ras-induced transformation processes (7,8). Likewise, 
insulin-driven oncoprotein metastasis (9,10) can be perceived in terms of a 
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persistently active growth-promoting (RB) peptide string which, in its mechanistic 
essence, may equally account for certain forms of chemical carcinogenesis for which a 
"protein deletion" mechanism had been proposed in the late 1940s (11). Therefore, it 
is likely that the degree of neutralization of an antineoplastic RB peptide information 
over spacetime would decide on the ultimate growth-inhibitory or growth-promoting 
nature of the corresponding RB peptide string. 
In the light of this underlying concept, one possible TKVD-based peptide 
string could be formed by extracellular and cytoplasmic IgG1 along with cytoplasmic 
and nuclear RB whereby the biological information encoded in the TKVD 
tetrapeptide would be passed on- similar to the baton within a relay race- primarily 
from internalized, cytoplasmic IgG1 to cytoplasmic RB through direct physical 
interaction and/or indirectly by the intermediary of another cytoplasmic (and 
nuclear) protein. 
Such intermediary could be the- cytoplasmic and nuclear (12)- clathrin heavy 
chain (CHC) whereby its type 1 isoform (CHC1) intriguingly harbors the TKVD 
tetrapeptide, as I have now found (notably, the type 2 CHC contains the highly 
related SKVD tetrapeptide, respectively, and could thus also serve as a functional link 
between IgG1 and RB). On the one hand, such possibility of an association between 
IgG1 and CHC is supported by a study showing clathrin-dependent IgG1 endocytosis 
(13) and, on the other hand, CHC may also contact RB given the close cytoplasmic 
proximity of the RB-binding protein p600 with clathrin (14). 
Interestingly, I have identified the TKVD peptide also in the Rac1 protein of 
the (extra- and intracellular) potentially pathogenic fungus Candida albicans (C. 
albicans), yet not in its human homologue (15). 
This finding suggested that an uncontrolled C. albicans infection may interfere 
in susceptible individuals with an TKVD-based immunoregulatory string through 
molecular mimicry of such (physiological) peptide string and, by engendering 
recognition of the TKVD self-epitopes on RB, CHC and IgG1 as cross-reactive 
epitopes, contribute to the autoimmune pathogenesis of RA. Remarkably, this 
hypothesis of mine is supported by the well-known association between (chronic) 
candidiasis and autoimmunity (16,17) as well as by the fact that C. albicans 
components can elicit an RA-like disease in experimental animals, albeit the chosen 
fungal immunogen was a ß-glucan, not a protein fragment in this setting (18). 
Yet, why would this deleterious cascade be initiated and proceed in some 
individuals and not be suppressed by anti-fungal defense mechanisms at an early 
stage? The potential answer likely resides in the peptide string normally opposing or 
rather counter-balancing the TKVD-based peptide string as part of a homeostatic 
process. Such anti-peptide string needs to be surmised as being deficient or 
dysfunctional in order for the TKVD-based peptide string to predominate in a 
pathologic manner. 
Before, however, further discussing this function, its structural details have to 
be defined. Based on the above peptide strings definition, the peptide string 
functionally opposite to the transcellularly conveyed TKVD amino acid information 
could be defined in a straightforward manner if a (self)binding site for TKVD was 
known. 
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In the absence of such knowledge, I therefore had to choose the equally 
possible alternative of identifying such anti-peptide string by searching for 
proteins/peptides known to antagonize/attenuate pathologic aspects of RA. My 
search yielded calcitonin as a possible candidate given that this hormone has been 
shown to have beneficial effects in the treatment of RA (19,20) which may be due to 
its previously demonstrated ability to inhibit macrophage function (21). Under the 
premise that calcitonin may contain peptide information overlapping with an existing 
anti-arthritogenic peptide string that involves RB and CHC under physiological 
circumstances, I performed a sequence comparison of all these molecules in the form 
of tripeptide sequences. This analysis yielded that RB and calcitonin share only the 2 
tripeptides Gly-Asn-Leu (GNL) and Asn-Leu-Ser (NLS) whereas CHC and calcitonin 
share the 7 tripeptides GNL, LST, TQD, QTA, TAI, IGV and VGA. 
Moreover, to achieve a perfect functional mirroring to the TKVD-based 
peptide string, an immunoglobulin had to be searched for that possibly shares with 
RB and/or CHC as well as calcitonin one of the above tripeptides. Following this 
insight, my additional exploration has yielded that, remarkably, the variable region of 
a distinct human immunoglobulin A1 heavy chain, briefly IgA1 VH (22), bears the 
NLS tripeptide whereas a comparable domain within the human IgG1 heavy chain 
(23) does not contain any of the above tripeptides. Notably, CHC harbors (in either of 
its two isoforms) the highly related sequence NFS. 
Along the same lines, I have detected the NLS sequence also in CD16 (i.e. a 
receptor specifically recognizing the constant region of its ligand IgG, briefly an Fc 
receptor), thus supporting the possibility of a direct physical interaction between 
TKVD (e.g. in IgG) and NLS (e.g. in CD16) peptide sequences, besides their above 
anticipated involvement in mediating  opposite biological effects. 
Since such found NLS sequences conform with the universal glycosylation 
motif NXS whereby X signifies any amino acid, the following intriguing scenario is 
conceivable. Normally, the NLS sequence in IgA1 VH may fullfill 2 roles: 
a) to antagonize Candida infection by neutralizing the TKVD peptide in the 
Rac1 protein of this fungus; 
b) to mask the TKVD epi/idiotope in IgG1 such that it is not recognized as an 
auto-antigenic site. As far as this second point is concerned and expressed differently, 
I assume that physiologically there are some IgA1 anti-idiotypic antibodies that, as 
part of an anti-arthritogenic idiotype network, suppress the "surfacing" of potentially 
autoimmune sites in (the constant region of) IgG1. Such host-beneficial masking of 
this IgG1 site would probably be performed not only by IgA1, but also by CD16. 
In this context, it should be specified that the TKVD tetrapeptide is located in 
close proximity to the IgG hinge region whose conformational change presumably 
accounts for the structurally altered serum IgG of RA patients as compared to that of 
healthy individuals (24,25), thus supporting the possibility that IgG1 TKVD may be 
unmasked as an auto-epitope for RF. Consistent with this prediction, Johnson and 
coworkers had presciently supposed that "new determinants are exposed at or near 
the hinge region of the rheumatoid IgG molecule" (26). Notably, the investigations 
carried out by Johnson et al. (25,26) have remained particularly important since they 
were performed with RA patient-derived IgG whereas subsequent (crystallization or 
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binding) studies were primarily conducted with artificially produced IgG (Fc 
fragment). 
Alternatively or additionally, the TKVD sequence could be self-targeted as part 
of an IgG fragment proteolytically generated during the disease process given that 
IgG degradation is a relevant aspect of RA pathogenesis (27,28). 
By contrast, if the above NLS site in IgA1 was abnormally glycosylated, this 
may impair both anti-microbial/anti-fungal defense (29) and the prevention of 
autoimmunity. The latter would be likewise affected in case the CD16 NLS sequence 
was also abnormally glycosylated. 
My present scenario is supported by the following facts. Firstly, it has been 
shown that (the onset of) RA coincides with aberrant glycosylation processes (30) 
that may affect not only IgG (31), but also other plasma proteins (32). Such 
phenomenon is complemented by the observation according to which this disease is 
also characterized by an insulin resistance along with a glucose utilization defect 
(33,34), ultimately promoting the emergence of AGE, i.e. advanced glycation 
endproducts (35), among which some may directly correlate with the activity of RA 
(36). 
Moreover and intriguingly, my present assumption on a causative IgA defect in 
RA is in full accordance with the well-known, yet poorly understood tendency of IgA-
deficient individuals to develop immune-complex disease (37) and, more generally 
viewed, with the increasingly appreciated link between immunodeficiency and 
autoimmunity (38,39).  
Since, furthermore, C. albicans Rac1 also contains the NLS peptide besides the 
TKVD peptide, it could be presumed that these peptide sequences are involved in the 
self-binding and folding of this protein. If, by contrast, (excessive) glycosylation 
occurred at its NLS site, the C. albicans Rac1 TKVD may be unmasked. Given that 
(diabetes mellitus-associated) hyperglycemic states are known to be associated with 
an increased frequency of fungal infections, it could be anticipated that such 
unmasked TKVD site contributes to the augmented virulence of these fungi under 
such conditions. 
Consequently, I would assume that at the root of RA there is a (metabolically 
induced, specifically AGE-associated) dysfunction in C. albicans-specific as well as 
anti-IgG1 anti-idiotypic IgA1 in the blood circulation, on the skin and/or on mucosal 
surfaces. 
As a result, Candida fungi could then invade host cells and spread throughout 
the body in an unchecked manner and, moreover, the TKVD epitope in IgG1, CHC 
and RB would be unmasked and thus become an autoimmune epitope due to the 
interference of the identical TKVD sequence in the Rac1 protein of C. albicans with 
(host-protective) NLS peptide-like domains in IgA1, CD16, CHC and RB. Ultimately, 
an anti-Candida immune response would be mounted that, due to the above 
mentioned antigenic similarity, is also directed against IgG1, CHC and RB. The 
putative self-neutralization of these 3 targets by RF(s) would conceivably engender 
the following molecular consequences: 
a) through its autoimmune destruction, IgG may no longer be able to auto-
regulate its own expression (40,41), thus exacerbating the concurrent IgA defect-
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based immunodepression towards specific foreign antigens and thus paving the way 
to a state of uncontrolled inflammation; 
b) CHC self-elimination would entrain a lack of termination of inflammation-
associated signalling since normally pro-inflammatory receptors such as TLR-4 are 
silenced by clathrin-associated endocytic recycling, thus further enhancing the hyper-
inflammatory mechanism described in a); 
c) RB self-targeting should be similarly detrimental as RB is likely to be a key 
conductor in the physiological repression of the inflammatory response (2) and thus 
its abolition would parallel its known inactivation by inflammatory mediators such as 
NF-kB, especially during hyper-inflammatory conditions. 
In keeping with this third point, it has been shown that RF cross-reacts with 
IgG and nuclear antigens the latter of which are not only histones (42) and, 
furthermore, that a subset of RA patients possesses antinuclear antibodies (ANA) 
directed against 105 and 95 kD antigens (43). These 2 autoantigens are conceivably 
RB isoforms, the former with its predominant molecular weight (44) and the latter 
potentially being a dysfunctional deletion variant as seen in human osteosarcoma 
cells (45). Moreover, a likely RA-preventive role of RB is also suggested by the fact 
that p21, i.e. one of its primary activators and inducers, inhibits interleukin-6 and 
matrix metalloproteinase-1 (46) since such p21 effect may well be mediated by RB 
similar to other p21-associated phenomena such as the cell cycle arrest induced by 
gamma-irradiation (47,48). 
If this scenario held true, then immunization of experimental animals with the 
TKVD peptide should cause an RA-like disease in them. 
Figs. 1a and 1b (cf. page 12) sketch the basic principles of dissemination of a 
given peptide information in the sense of a peptide string. 
Tables 1-3 (cf. page 13) summarize this peptide strings view on normal TKVD- 
as well as NLS peptide-based immunoregulation vs. early and advanced forms of RA 
("hum." is the abbreviation for "human", the term "amino acid" has been abridged as 
"aa", square brackets indicate diminished function, crossed lines signify the 
destruction of the respectively specified protein, absence of an involved protein in a 
certain table box corresponds to its functional silencing and red color highlights the 
predominant peptide string). 
Furthermore, Fig. 2 (cf. page 14) represents an application of the tenets of Fig. 
1 to the contents of Tables 1-3 and, as such, displays how e.g. the propagation of the 
TKVD autoimmune peptide information could be imagined under primarily 
stereospecific or steric considerations. 
Last but not least, Fig. 3 (cf. page 15) represents a further abstraction and 
simplification  of the same scenario as it focuses on capturing it in the form of two 
opposite facets of an immunoregulatory peptide string for RB- depicted in a graphical 
form that has previously been introduced to illustrate growth-regulatory RB peptide 
strings (5)- whereby the NLS-based (anti-inflammatory, anti-arthritogenic) RB string 
predominates under physiological conditions (Fig. 3A) and, by contrast, the TKVD-
based (pro-inflammatory/arthritogenic/autoimmune) RB string prevails during RA 
(Fig. 3B). Thus, in the former case, it is the NLS sequence which, in analogy to 
Mendel´s genetic traits, could be considered as functionally "dominant" over the 
Radulescu Rheumatoid arthritis peptide strings arXiv August 10, 2008 
 - 8 - 
functionally "recessive" TKVD whereas, in the latter case, these features would be 
reversed. 
Consequently, a possible future treatment of early-stage RA could include C. 
albicans-specific anti-fungal agents. 
Yet, in order to catch up with a potential autoimmune cascade of events 
already initiated by C. albicans, the present peptide strings interpretation of RA 
suggests that it may be necessary to administer a peptide comprising the above Asn-
Leu-Ser or Asn-Phe-Ser sequence, briefly an NL/FS amino acid signature, in 
pharmacological doses in order to mask the potentially arthritogenic TKVD 
tetrapeptide such that it is no longer visible for an overreacting immune system and 
hence to curtail the inflammatory response against this antigen by restoring the 
natural balance or homeostasis between TKVD and NL/FS peptide strings which, 
similar to the predominance of growth-inhibitory peptide strings in the normal state 
(5), would be asymmetric such that anti-inflammatory NL/FS peptide strings would 
prevail to a certain degree.  
Moreover, the NL/FS peptide-based "epitope masking therapy" I am 
proposing here would have to be administered systemically and such that it reaches 
the inside of all cells in the body. 
The reason therefore is that peptide strings, whether agonistic or antagonistic, 
describe a generalized transcellular condition with resemblance (5) to the resonance 
thought to govern chemical bonds the latter of which is an arbitrary and idealized, yet 
valuable quantum mechanical approximation (49). Hence, a pathogenic peptide 
strings condition could only be reversed by an opposite, likewise generalized (also 
resonance-like) state that is not limited to a single antigenic molecule or distinct 
target cell, but instead recruits a common peptide motif in various proteins within 
and across many different cells (4,5). 
Should future studies choose to experimentally explore, besides the previously 
reported growth-regulatory peptide strings (3-5) and their corrolaries (9,10), also this 
peptide string scenario for RA and its therapeutic counterpart, there is a fair chance 
that not only a fundamentally new signal transmission mode- partly resembling the 
(free radical) chain reactions described by Semenov (50)- will be further understood, 
but that additionally Szent-Györgyi´s bold and long-standing expectation of 
quantum-mechanical explanations for otherwise elusive biological processes (51) will 
finally be specifically addressed along the way. 
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Fig. 1 
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Fig. 1a Peptide information transfer from an outer cue (red) to a bipartite, self-
complementary/self-binding protein with a subdomain (green) resembling the cue 
whereby such subdomain would be sterically or allosterically exposed upon binding of 
the cue to such protein, thus initiating a peptide string. 
 
Fig. 1b Peptide information transfer from the protein specified in a) to another bipartite, self-
complementary/self-binding protein with a subdomain (purple) resembling both the 
cue and the cue-like subdomain in the protein initially bound by the cue whereby in 
the course of this protein-protein interaction such subdomain in the second protein 
would be sterically or allosterically exposed, thus further propagating or disseminating 
the peptide string initiated by the cue. 
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Tab. 1 
 
NORMAL 
 
Arthritogenic peptide string 
 
Anti-arthritogenic peptide 
string 
 
Extracellular 
environment 
 
Thr-Lys-Val-Asp  hum.IgG1 CH (aa 209-212) 
 
Asn-Leu-Ser     hum.IgA1 VH (aa 28-30) 
Asn-Leu-Ser     hum.CD16 (aa 71-73) 
Asn-Leu-Ser     hum.calcitonin (aa 3-5) 
 
Cytoplasm 
 
Thr-Lys-Val-Asp  hum.IgG1 CH (aa 209-212) 
Thr-Lys-Val-Asp  hum.CHC1 (aa 1608-1611) 
Thr-Lys-Val-Asp  hum.RB (aa 142-145) 
 
Asn-Leu-Ser     hum.IgA1 VH (aa 28-30) 
Asn-Phe-Ser     hum.CHC1 (aa 720-722) 
Asn-Leu-Ser     hum.RB (aa 316-318) 
 
Nucleus 
 
Thr-Lys-Val-Asp  hum.CHC1 (aa 1608-1611) 
Thr-Lys-Val-Asp  hum.RB (aa 142-145) 
 
Asn-Phe-Ser     hum.CHC1 (aa 720-722) 
Asn-Leu-Ser     hum.RB (aa 316-318) 
 
 
Tab. 2 
 
EARLY 
RHEUMATOID 
ARTHRITIS 
 
Arthritogenic peptide string 
 
Anti-arthritogenic peptide 
string 
 
Extracellular 
environment 
 
Thr-Lys-Val-Asp   C.albicans Rac1 (aa 116-119) 
Thr-Lys-Val-Asp   hum.IgG1 CH (aa 209-212) 
 
[Asn-Leu-Ser    hum.IgA1 VH (aa 28-30)] 
[Asn-Leu-Ser    hum.CD16 (aa 71-73)] 
[Asn-Leu-Ser    hum.calcitonin (aa 3-5)] 
 
Cytoplasm 
 
Thr-Lys-Val-Asp   C.albicans Rac1 (aa 116-119) 
Thr-Lys-Val-Asp   hum.IgG1 CH (aa 209-212) 
Thr-Lys-Val-Asp   hum.CHC1 (aa 1608-1611) 
Thr-Lys-Val-Asp   hum.RB (aa 142-145)  
 
 
[Asn-Leu-Ser    hum.IgA1 VH (aa 28-30)] 
[Asn-Phe-Ser    hum.CHC1 (aa 720-722)] 
[Asn-Leu-Ser    hum.RB (aa 316-318)] 
 
Nucleus 
 
Thr-Lys-Val-Asp   hum.CHC1 (aa 1608-1611) 
Thr-Lys-Val-Asp   hum.RB (aa 142-145) 
 
[Asn-Phe-Ser    hum.CHC1 (aa 720-722)] 
[Asn-Leu-Ser    hum.RB (aa 316-318)] 
 
 
Tab. 3 
 
ADVANCED 
RHEUMATOID 
ARTHRITIS 
 
Arthritogenic peptide string 
 
Anti-arthritogenic peptide 
string 
 
Extracellular 
environment 
 
[Thr-Lys-Val-Asp  C.albicans Rac1 (aa 116-119)] 
Thr-Lys-Val-Asp  hum.IgG1 CH (aa 209-212) 
 
 
 
Cytoplasm 
 
[Thr-Lys-Val-Asp  C.albicans Rac1 (aa 116-119)] 
Thr-Lys-Val-Asp  hum.IgG1 CH (aa 209-212) 
Thr-Lys-Val-Asp  hum.CHC1 (aa 1608-1611) 
Thr-Lys-Val-Asp  hum.RB (aa 142-145) 
 
 
 
Asn-Phe-Ser     hum.CHC1 (aa 720-722) 
Asn-Leu-Ser     hum.RB (aa 316-318) 
 
Nucleus 
 
Thr-Lys-Val-Asp  hum.CHC1 (aa 1608-1611) 
Thr-Lys-Val-Asp  hum.RB (aa 142-145) 
 
Asn-Phe-Ser     hum.CHC1 (aa 720-722) 
Asn-Leu-Ser     hum.RB (aa 316-318) 
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Fig. 2 
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Fig. 2a Peptide information transfer from an outer cue carrying the TKVD amino acid 
sequence (red) to a bipartite, self-complementary/self-binding protein with a 
subdomain (green) harboring the same tetrapeptide whereby such subdomain would 
be sterically or allosterically exposed upon binding of the cue to another subdomain in 
such protein containing the NLS tripeptide, thus initiating a TKVD peptide string. 
 
Fig. 2b Peptide information transfer from the "cue-activated" protein specified in a) to 
another bipartite, self-complementary/self-binding protein comprising both the TKVD 
sequence (purple) and the NLS tripeptide whereby the TKVD tetrapeptide of the 
second protein would be sterically or allosterically exposed upon this protein-protein 
interaction, thus further propagating or disseminating the TKVD peptide string 
initiated by the cue. 
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Fig. 3 
 
 
         anti-inflammatory 
(e.g. anti-arthritogenic) 
         RB string 
A.          
     NLS         TKVD         NLS       TKVD       NLS 
 
 
         pro-inflammatory 
         (e.g. arthritogenic) 
         RB string 
B.     TKV(D)       TKV(D) 
      NLS          TKVD        NLS         TKVD     NLS 
 
 
Fig. 3A anti-inflammatory peptide string for retinoblastoma protein (RB) corresponds to a 
majority of RB molecules with an exposed Asn-Leu-Ser, briefly NLS, fragment and a 
minority of RB molecules with an exposed Thr-Lys-Val-Asp, briefly TKVD, fragment in 
a certain spacetime; 
 
Fig. 3B pro-inflammatory peptide string for RB corresponds to a majority of RB molecules 
with an exposed Thr-Lys-Val-Asp, briefly TKVD, fragment and a minority of RB 
molecules with an exposed Asn-Leu-Ser, briefly NLS, fragment in a certain spacetime. 
 
